|
I.A. Oganezova, E.B. Avalueva
HELICOBACTER PYLORI-NEGATIVE PEPTIC ULCER DISEASE: HISTORICAL FACTS AND MODERN REALITIES
|
№s5-17 / 2017
|
|
D.N. Andreev, I.V.Maev, D.T. Dicheva, Y.A. Kucheryavy
INTEGRATED ASSESSMENT OF SAFETY OF TWO MODES OF ERADICATION THERAPY OF HELICOBACTER PYLORI INFECTION IN PATIENTS WITH CHRONIC HEPATITIS C
|
№2 / 2016
|
|
Andreev D.N., Maev I.V., Dicheva D.T., Kucheryavy Yu.A., Partsvania-Vinogradova E.V.
ANALYSIS OF INFLUENCE OF LIVER FIBROSIS ON EFFICACY AND SAFETY OF ANTI-HELICOBACTER THERAPY
|
№20 / 2015
|
|
Mayev I.V., Samsonov A.A., Kochetov S.A., Korovina T.I., Karaulov S.A., Andreyev N.G.
Inclusion Of The Bismuth And Esomeprazole In The Triple Eradication Therapy: A Simple Way To Increase The Effectiveness Of Treatment
|
№7 / 2012
|
|
Stupin V.A., Siluyanov S.V., Afanasev V.V., Baglaenko M.V., Sabirov M.A., Smirnova G.O.
Features Of Conservative Therapy For Patients With Bleeding Ulcers Of The Stomach And Duodenum
|
№2 / 2011
|
|
Maev I.V., Andreev N.G., Samsonov A.A., Belyavceva E.V.
Antacids As A Essential Component Of Modern Treatment Of Acid-related Digestive Disorders
|
№2 / 2011
|
|
Milenin D.O.
Microbial Biofilm Of Helicobacter Pylori And Its Role In The Pathogenesis Of Peptic Ulcer Of The Stomach And Duodenum
|
№20 / 2010
|
|
I.V. Maev, A.N. Kazyulin, D.T. Ditcheva, T.A. Buragina
Risk Factors And Treatment Of Not Cicatrizing Stomach And Duodenal Ulcers
|
№15 / 2010
|
|
A.Kalinin, A.Loginov
Symptomatic Gastro-duodenal Ulcers
|
№2 / 2010
|
|
M.A. Butov, E.Yu. Karpova
Influence Of Different Variants Of Eradication Therapy On Indices Of Non-specific Colon Immunity And Microbiocenosis In Patients With Peptic Ulcer Disease
|
№13 / 2009
|
Русский
